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Angiotensin II (AII), a product of rennin-angiotensin system, exerts an important role on the function of immune
system cells. In this study, the effect of AII on the phagocytic activity of mouse peritoneal macrophages was assessed.
Mice peritoneal macrophages were cultured for 48 h and the influence of different concentrations of AII (10-14 to
10-7 M) and/or losartan, 10-16 to 10-6 M), an AT1 angiotensin receptor antagonist, on phagocytic activity and
superoxide anion production was determined. Dimethylthiazoldiphenyltetrazolium bromide reduction and the nucleic
acid content were used to assess the cytotoxicity of losartan. A stimulatory effect on phagocytic activity (P < 0.05)
was observed with 10-13 M and 10-12 M AII concentrations. The addition of losartan (up to10-14 M) to the cell
cultures blocked (P < 0.001) the phagocytosis indicating the involvement of AT1 receptors. In contrast, superoxide
anion production was not affected by AII or losartan. The existence of AT1 and AT2 receptors in peritoneal macroph-
ages was demonstrated by immunofluorescence microscopy. These results support the hypothesis that AII receptors
can modulate murine macrophage activity and phagocytosis, and suggest that AII may have a therapeutic role as an
immunomodulatory agent in modifying the host resistance to infection.
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In recent years, much insight has been gained in the
biochemical pathways by which angiotensin II (AII) ex-
erts its effects on cells. In particular, the cloning of the A
II receptors AT1A, AT1B, and AT2 has led to better under-
standing of how AII interacts with different cells to pro-
duce its physiological responses (Regitz-Zagrosek et al.
1996, Lavoie & Sigmund 2003).
The renin-angiotensin system (RAS) is an important
regulatory mechanism for cardiovascular homeostasis in
normal and hypertensive subjects (Brewster et al. 2003,
Lavoie & Sigmund 2003). Previous reports have shown
that macrophages from different tissues express compo-
nents of the RAS (Nickening et al. 1997, Lamparter et al.
1998) and granuloma macrophages can synthesize angio-
tensin (Weinstock & Blum 1987). In addition, high levels
of renin mRNA are expressed by monocytes and mac-
rophages in the necrotic myocardium (Iwai et al. 1996).
The ability of AII to stimulate cardiac fibroblast prolifera-
tion and extracellular matrix (ECM) synthesis by these
cells suggests an important role for AII in ventricular re-
modeling. This conclusion agrees with the demonstra-
tion that AII can influence the accumulation of ECM and
the synthesis of type I collagen, fibronectin, biglycan,
and growth factors (Wolf et al. 1992, Matisusaka &
Ichikawa 1997).
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The presence of specific AII binding sites in macroph-
ages has been suggested by several studies (Dezso &
Fóris 1981, Thomas & Hoffman 1984, Dezso et al. 1988).
Prabha et al. (1990) were the first to show that at physi-
ological concentrations, AII can increase free-radical gen-
eration by polymorphonuclear neutrophils. Kumar and Das
(1993) subsequently confirmed this observation. Hydro-
gen peroxide, peroxide, and superoxide production via
AT1 receptors is an important component in the respira-
tory burst response that can be used to measure the acti-
vation of macrophages (Scheidegger et al. 1997, Jaimes et
al. 1998, Pueyo et al. 1998, Yanagitani et al. 1999).
Based on these reports, this study was designed to
investigate the role of AT1 receptors in the phagocytic
activity and superoxide release of mouse peritoneal mac-
rophages. The effect of AII on these cells was determined
in the absence and presence of losartan, an AT1 receptor
antagonist. We also evaluated the cytotoxic effect of
losartan and the presence of AT1 and AT2 receptors on
peritoneal macrophages.
MATERIALS AND METHODS
Cultures of macrophages  - Male Balb/C mice 6-8 weeks
old were supplied by the Central Animal House (Unicamp).
The experimental protocols described here were approved
by the institutional Committee for Ethics in Animal Experi-
mentation. Macrophages were harvested from the perito-
neal cavities of mice and were resuspended in Hanks’
balanced salt solution (HBSS) (Sigma Chemical Co., St.
Louis, MO). The number of viable cells was determined
by trypan blue dye exclusion. The resuspended macroph-
ages (2 x 105 cells/well) were allowed to adhere to round
13 mm glass coverslips placed in 24-well plates (Corning
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Inst., NY, US). Non adherent cells were removed by rising
the coverslips with HBSS and the adherent cells were in-
cubated in 1 ml of Roswell Park Memorial Institute (RPMI-
1640) medium (Sigma) supplements with 10% fetal bovine
serum at 37°C in a 5% CO2 humidified atmosphere. After
48 h the cells were washed three times with serum-free
RPMI 1640 medium and incubated for 1 or 3 h in the pres-
ence of 10-14-10-7 M AII (Sigma) alone or with different
concentrations 1014-10-4 M) of losartan (DuPont de
Nemours & Co., Wilmington, DE). The AII and losartan
solutions were prepared in serum-free RPMI 1640 medium.
Control cultures were incubated with serum-free RPMI-
1640 medium.
Opsonized zymosan - Twenty milligrams of zymosan A
(Sigma) dissolved in 1 ml of PBS (phosphate-buffered
saline, pH 7.4) were added to 3 ml of pooled normal mouse
serum and incubated for 15 min at 37°C with mixing. The
particles were washed three times with PBS and resus-
pended in the same solution for the phagocytic assays.
Phagocytic assay - Macrophage monolayers were ob-
tained as described above and the coverslips were washed
with HBSS. Opsonized zymosan particles were added to
the monolayers in a 5:1 (particle: macrophage) ratio and
the coverslips incubated at 37°C in a 5% CO2 humidified
atmosphere. After 30 min, the coverslips were washed with
HBSS, fixed in methanol, and stained with Giemsa. After
drying, the coverslips were mounted on glass slides and
examined microscopically. The percentage of cells with
ingested particles was multiplied by the average number
of particles per macrophage to calculate phagocytic in-
dex. At least 100 macrophages were counted per cover-
slip.
Dimethylthiazoldiphenyltetrazolium bromide (MTT)
assay - The tetrazolium reduction assay was done as de-
scribed by Denizot and Lang (1986). Briefly, macrophages
were incubated for  4 h with 1 ml of serum-free medium
containing 2 mg of MTT/ml (Sigma). The culture medium
was removed and the blue formazan product obtained was
solubilized in 1 ml of ethanol with shaking for 15 min on a
microtiter plate shaker. The resulting absorbance was
measured at 570 nm.
Nucleic acid content - The number of cells in control
and treated wells was estimated from their total nucleic
acid content according to Cingi et al. (1991). The cells
were washed twice with cold PBS and a soluble nucle-
otide pool was extracted with cold ethanol. The cells mono-
layers were then dissolved in 0.5 M NaOH for 1 h at 37°C,
and the absorbance of the lysate was used as an index of
the  number of cells. The results were expressed as a per-
centage of the absorbance at 260 nm obtained for the
controls.
Superoxide anion production - Superoxide produc-
tion by the macrophages was measured by the reduction
of ferricytochrome C (Sigma) as described by Pick and
Mizel (1981). Peritoneal cells (2 x 105 cells/well) were incu-
bated with reaction solution containing 80 µM
ferricytochrome C with zymosan particles in a 5:1 (par-
ticle: macrophage) ratio in HBSS. The amount of
ferricytochrome C reduced by superoxide was measured
spectrophotometrically at 550 nm. Wells containing me-
dium and ferricytochrome C only were used as controls.
The total superoxide anion production was calculated
using the formula:
Superoxide (nmoles) = A550 x [volume of incubation
mixture (ml)] x 47.4 (Absolom 1986), where A550, is the
peak height or maximum absorbance at 550 nm. Superox-
ide generation was calculated by assuming that a change
in absorbance of 1.0 at 550 nm corresponded to the pres-
ence of 47.4 nmol of superoxide. The extinction coeffi-
cient for ferricytochrome C at 550 nm was considered to
be 21,000 M-1 . cm-1.
Preliminary experiments showed that superoxide pro-
duction by peritoneal cells was completely inhibited by
the presence of superoxide desmutase. After the removal
of non-adherent cells, the macrophages were covered with
1 ml per well of 1 N NaOH and incubated overnight at
37°C in a humidified incubator. The following day, the
NaOH digest from all wells was pooled and the protein
content was determined by the method of Lowry et al.
(1951), using bovine serum albumin as standard. The mean
protein content (mg) per well determined in this assay
was used to express the superoxide production by the
cells, and was expressed as nmoles of superoxide pro-
duced per mg of protein per hour.
Immunofluorescence staining - Coverslips with mac-
rophage monolayers were fixed in methanol (20°C) for 1 h.
The cells were washed with cold PBS and non-specific
binding sites were blocked with milk (3%) for 1 h at room
temperature. After extensive washing, the cells were incu-
bated overnight (4°C) with anti-AT1 rabbit IgG (Santa Cruz)
or anti-AT2 goat IgG (Santa Cruz) at a dilution of 1:50. The
cells were then washed with PBS and incubated for 2 h at
room temperature with anti-rabbit IgG FITC (1:100) and
anti-goat IgG FITC (1:200). The coverslips were mounted
with antifading Vectashield media. The immunofluores-
cence staining was examined in a Bio-Rad scaning laser
confocal microscope equipped with an Axovert 100 mi-
croscope (Boer-Lima et al. 2002).
Statistical analysis - Where appropriate, the results
were expressed as the mean ± SEM. Statistical signifi-
cance was assessed by ANOVA for repeated measure-
ments followed by the Tukey post-hoc test to determine
the extent of the differences using the SAS (Statistical
Analysis System, version 6.12). A significance level of
5% was chosen.
RESULTS
Phagocytic assay - The effect of AII on the phago-
cytic activity of macrophages was evaluated over the con-
centration of 10-14 to 10-4M. Exposure to 10-13 M and
10-12 M AII significantly potentiated (p < 0.05) zymosan-
induced phagocytosis after 1 and at 10-12 M AII after 3 h
in a concentration-dependent fashion (Fig. 1). Fig. 2 shows
that losartan, a AII receptor antagonist, blocked the stimu-
latory effect of 10-12 M AII on phagocytosis up to 10-14
M AII concentration tested, with complete inhibition oc-
curring at 10-6 M losartan (p < 0.001) (Fig. 1C). When the
incubation time was increased to 3 h, losartan alone in-
hibited phagocytosis at concentrations ranging from
10-12 M to 10-4 M. Similar results were observed in the
presence of 10-12 M AII, with a major effect at 10-6 M of
losartan (p < 0.001) (Fig. 1D).
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Cytotoxicity assays - To assess whether the inhibi-
tory effect of losartan on macrophage phagocytic activ-
ity was due to the blockade of AT1 receptors, citotoxicity
assays were done using the same losartan concentrations
as described in the experiments above. No toxic effect
was observed when macrophages were incubated with
losartan at any of the concentrations tested (Fig. 2). Sur-
prisingly, however, an increase in the nucleic acid content
was observed after a 1 h incubation with 10-4 M losartan
(Fig. 2A).
Superoxide anion production - The concentration of
AII (10-12 M) that stimulated phagocytosis and this of
losartan (10-6 M), which inhibited phagocytosis, did not
significantly influence the superoxide production by mac-
rophages, even after a 3 h exposure to the drugs (Fig. 2C).
Immunofluorescense - Immunohistochemistry gave a
positive reaction for AT1 and AT2 receptors. Pretreating
the cells with 10-12 M AII increased the intensity of AT1
receptor staining (Fig. 3B). In contrast treatment with
10-6 M losartan or with AII + losartan decreased the num-
ber of receptors stained (Fig. 3C, D). Similar results were
observed with AT2 receptors when the cells were treated
with 10-12 M AII (Fig. 3F).
DISCUSSION
Components of the RAS are present in isolated liver
granulomas associated with murine schistosomiasis, and
granuloma macrophages have receptors for AII. These
observations, along with other  evidence (Iwai et al. 1996),
suggest that angiotensin II has a  role in immunoregulation.
Since AII can stimulate actin-myosin interactions and
since macrophages have contractile proteins, the ability
of AII to alter the phagocytic activity of granuloma mac-
rophages was examined (Weinstock & Blum 1987, Iwai et
al. 1996, Nickening et al. 1997, Lamperter et al. 1998). At
concentrations, which saturate the AII receptors, AII en-
hanced the phagocytic activity of opsonized and uno-
psonized sheep red blood cells (RBC). Using a DNase
inhibitory assay, similar concentrations of AII were found
to intracellular actin polymerization. Cytochalasin B, which
Fig. 1: dose-dependent effect of angiotensin II and/or losartan on the phagocyte activity of peritoneal macrophages. Peritoneal macroph-
ages were exposed in vitro to various concentrations of AII (n = 9), losartan and AII (10-12 M, n = 9) + losartan for 1 h (A and C, n = 9
for each experimental group) or 3 h (D, n = 9), and then incubated with zymosan solution for 30 min to determine phagocytic activity.
Control cells (Co) were incubated with Roswell Park Memorial Institute (RPMI-1640) medium alone. Statistical significance was assessed
by ANOVA for repeated measurements followed by the Tukey post-hoc test to determine the extent of the differences. The data are
expressed as means ± SEM. Two hundred cells were counted per sample.
Control
All
1-h
A300
250
200
150
100
50
0
300
250
200
150
100
50
0
*
*
350
300
250
200
150
100
50
0
350
300
250
200
150
100
50
0
Control
All
losartan+All
losartan
*
*
*
* *
*
C
B D3-h
Ph
ag
oc
yt
ic 
in
de
x
Ph
ag
oc
yt
ic 
in
de
x
Ph
ag
oc
yt
ic 
in
de
x
Ph
ag
oc
yt
ic 
in
de
x
* *
*
*
*
*
*
All vs losartan + All (p< 0.05, ANOVA)
All vs losartan (p < 0.001, ANOVA)
*p < 0.001 (Co vs All)
Co  All -16     -14     -12      -7      -6
(losartan) log M
Co  -14     -13     -12      -7
(All) log M
170  Peritoneal Macrophage Activity • Paula Belline et al.
impedes actin filament interactions, inhibited AII-stimu-
lated phagocytosis AII analogs with little agonist activity
blocked AII-stimulated actin polymerization and the ph-
agocytosis  of non-opsonized RBC and of RBC opsonized
with IgG. These data support the contention that AII binds
to AII receptors on macrophages and stimulates phago-
cytosis possibly through the polymerization of intracel-
lular actin. AII of the components of the RAS, except for
chymase, have been demonstrated in macrophages
(Okamura et al. 1999). AII is involved in rosette formation
and in the phagocytosis associated with the contractile
elements of the cell, thereby affecting the cytoskeleton
(Dezso & Fóris 1981, Fóris et al. 1983, Weinstock & Blum
1987, Dezso et al. 1988). Our results are consistent with
these data and suggest that the RAS may have an impor-
tant function in the phagocytic activity of macrophages.
The concentration response curve for angiotensin II in-
duced phagocytosis was bimodal, with the greatest stimu-
lation at 10-13 M and 10-12 M AII concentrations tested.
To determine whether this stimulation occurred via
AT1 receptors, the cells were incubated with the AT1 an-
tagonist losartan prior to the determination of phagocy-
tosis. A decrease in  phagocytic activity was observed
after a 1 h incubation with 10-6 M losartan. When the
cells were incubated with different concentrations of
losartan in the presence of 10-12 M AII there was a de-
crease in the phagocytic index, thus demonstrating the
blockade of AT1 receptors and their involvement in ph-
agocytosis. When the incubation was increased to 3 h,
losartan alone inhibited phagocytosis in the concentra-
tion range of 10-12 to 10-6 M, while in the presence of
10-12 M AII, concentrations up to 10-14 M of losartan
tested also effectively prevented AII-induced increases
in phagocytic function. This inhibitory action of losartan
was not due to cytotoxicity since losartan did not affect
cell viability as assessed by the MTT reduction and nucleic
acid content. These results indicate that the binding of
AII to AT1 receptors is essential for the activation of ph-
agocytosis in macrophages.
In addition of phagocytic activity, the effect of AII
and losartan on the production of superoxide anions was
investigated using ferricytochrome C reduction.
Mesangial cells exposed to AII (10-7 M to 10-5 M) show a
significant increase in superoxide production mediated
by AT1 receptors (Jaimes et al. 1998). In peritoneal mac-
rophages, the concentrations of AII and losartan which
stimulated and inhibited phagocytosis, respectively, did
not influence superoxide production, perhaps because the
concentrations tested were not optimal.
Immuonofluorescense microscopy identified AT1 and
AT2 receptors on peritoneal macrophages treating the
cells with AII and losartan changed the immunoreactivity
with AII increasing the number of AT1 and AT2 receptors,
whereas losartan decreased the intensity of the immu-
nofluorescense. Together, these results suggest that AII
receptors may modulate murine macrophage activity and
phagocytosis is dissociated from free-radical generation.
Perspectives - Our results support the hypothesis that
angiotensin can directly modulate peritoneal macrophage
function, and may have a therapeutic role as an immu-
nomodulatory agent in modifying the host resistance to
infection.
Fig. 2: macrophage viability evaluated by the nucleic acid content
(NAC) and MTT (dimethylthiazoldiphenyltetrazolium bromide)
reduction assay, and superoxide anion release by peritoneal mac-
rophages (C) after treatment with AII (10-12 M, n = 8), losartan
(10-6 M, n = 8) and angiotensin II + losartan (n = 8 for each time)
for 1 h (A) or 3 h (B). The data are reported as the mean ± SEM of
two independent experiments each run in  quadruplicate. Statistical
significance was assessed by ANOVA test for repeated measure-
ments. A P value ≤ 0.05 was considered to indicate statistical sig-
nificance. The data were expressed as a percentage of the corre-
sponding control value.
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Fig. 3:  immunoreactive AT1 receptors in mouse peritoneal macrophages. A: control group; B: macrophages treated for 1 h with
angiotensin II (10-12M); C: macrophages treated for 1 h with losartan (10-6M); D: macrophages treated for 1 h with AII and losartan.
Immunoreactive AT2 receptors in mouse peritoneal macrophages (E, F); E: control group; F: macrophages treated for  1 h with AII(10-12 M).
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